Analyze Diet
Equine veterinary journal1971; 3(3); 110-113; doi: 10.1111/j.2042-3306.1971.tb04450.x

Treatment of atrial fibrillation in the horse with intravenous dihydroquinidine gluconate.

Abstract: No abstract available
Publication Date: 1971-07-01 PubMed ID: 5161362DOI: 10.1111/j.2042-3306.1971.tb04450.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates the use of intravenous dihydroquinidine gluconate as a potential alternative in the treatment of atrial fibrillation in horses, suggesting the method may help overcome various challenges associated with the commonly used method of oral quinidine sulphate administration.

Background

  • The research is centered on the treatment of atrial fibrillation in horses – a health condition in which the upper chambers of the heart, the atria, beat irregularly, leading to a chaotic and inefficient flow of blood.
  • Traditionally, oral administration of quinidine sulphate has been considered the preferred treatment method for this condition. However, this method has various known difficulties, such as the risk of toxicity due to high dosage levels, the danger of acute laminitis (a painful inflammation in the foot of the horse), causing distress to the horses by repeated balling or passing of the stomach tube, and the safety risk posed by unruly horses to the individuals administering the drug.

Purpose of the Study

  • Given these issues, the research sets out to examine an alternative treatment method for atrial fibrillation in horses. The researchers consider dihydroquinidine gluconate, admininstered intravenously, as a potential solution to overcome the issues associated with oral administration of quinidine sulphate.

Description of Cases

  • The researchers intend to discuss two case studies. One horse was treated with traditional oral doses of quinidine sulphate (at unusually high dosage levels), while the other was the first horse at their clinic to be treated with intravenous dihydroquinidine gluconate.
  • Both horses used in the study were 8-year-old geldings (castrated male horses) and international show jumpers. They were known to end their rounds in an exhausted state, and according to referring veterinarians, both had suffered from atrial fibrillation for at least a year before they were admitted to the clinic.

Methodology

  • After admission, each horse was examined daily with electrocardiograms recorded before treatment and afterwards when necessary. Additional electrocardiograms were taken whenever the horses were ridden, both before and after the exercise.
  • Haematological examinations were carried out at least once or twice each week and included packed cell volume, haemoglobin estimations, and red and white cell counts. In one case, more in-depth observations consisted of weekly tests of enzyme activities, and estimations of bilirubin, cholesterol, urea, iron, and copper concentrations.

Cite This Article

APA
Gerber H, Chuit P, Schatzmann HJ. (1971). Treatment of atrial fibrillation in the horse with intravenous dihydroquinidine gluconate. Equine Vet J, 3(3), 110-113. https://doi.org/10.1111/j.2042-3306.1971.tb04450.x

Publication

ISSN: 0425-1644
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 3
Issue: 3
Pages: 110-113

Researcher Affiliations

Gerber, H
    Chuit, P
      Schatzmann, H J

        MeSH Terms

        • Administration, Oral
        • Animals
        • Atrial Fibrillation / drug therapy
        • Atrial Fibrillation / physiopathology
        • Atrial Fibrillation / veterinary
        • Electrocardiography
        • Gluconates / administration & dosage
        • Gluconates / therapeutic use
        • Horse Diseases / drug therapy
        • Horse Diseases / physiopathology
        • Horses
        • Injections, Intravenous
        • Male
        • Quinidine / administration & dosage
        • Quinidine / therapeutic use
        • Sulfates / administration & dosage
        • Sulfates / therapeutic use

        Citations

        This article has been cited 2 times.
        1. Decloedt A, Schwarzwald CC, De Clercq D, Van Der Vekens N, Pardon B, Reef VB, van Loon G. Risk factors for recurrence of atrial fibrillation in horses after cardioversion to sinus rhythm. J Vet Intern Med 2015 May-Jun;29(3):946-53.
          doi: 10.1111/jvim.12606pubmed: 25917409google scholar: lookup
        2. Rivard G. [A case of auricular fibrillation in a competition horse]. Can Vet J 1977 May;18(5):122-6.
          pubmed: 872029